Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Aug 16, 2024

SELL
$63.15 - $90.42 $442 - $632
-7 Closed
0 $0
Q4 2021

Aug 16, 2024

SELL
$77.28 - $99.42 $2,395 - $3,082
-31 Reduced 81.58%
7 $630,000
Q3 2021

Aug 16, 2024

BUY
$65.97 - $92.48 $2,506 - $3,514
38 New
38 $3.51 Million
Q1 2021

Aug 16, 2024

SELL
$72.25 - $168.95 $1,517 - $3,547
-21 Reduced 50.0%
21 $1.57 Million
Q2 2020

Aug 16, 2024

SELL
$93.0 - $171.7 $744 - $1,373
-8 Reduced 16.0%
42 $6.73 Million
Q1 2020

Aug 16, 2024

BUY
$82.38 - $131.64 $164 - $263
2 Added 4.17%
50 $4.89 Million
Q4 2019

Aug 16, 2024

BUY
$76.53 - $135.58 $3,673 - $6,507
48 New
48 $6.19 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.4B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Td Private Client Wealth LLC Portfolio

Follow Td Private Client Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.